Temporal trends in measles incidence rates vary by different vaccination delivery strategies; the measles burden decreases with additional vaccination delivery strategies. For countries that have not yet introduced MCV2 (ie, Uganda, DR Congo, and Somalia), there are overlapping trends for incidence rates for the delivery strategies of MCV1 and MCV2 (blue lines) and MCV1 only (green lines) and the delivery strategies of MCV1, MCV2, and SIAs (purple lines) and MCV1 and SIAs (red lines). Overlapping trends are also seen in most analysed years in countries that introduced MCV2 after 2017 (ie, Nigeria, Ethiopia, and Madagascar). In Indonesia, the fluctuations seen in the no vaccination strategy are the result of dynamic sizes of the susceptible population affected by natural seasonality of measles transmission. MCV1=the first routine dose of measles-containing vaccine. MCV2=the second routine dose of measles-containing vaccine. SIA=supplementary immunisation activity.